In a significant ruling aimed at curbing unethical medical practices, the Supreme Court of India has categorically barred the use of stem cell therapy as a clinical treatment for Autism Spectrum Disorder (ASD).
Declaring such interventions outside approved and regulated clinical trials to be unethical and legally impermissible, the court held that offering unproven stem cell treatments to autistic patients amounts to medical malpractice.